GEN-PROBE (NASDAQ:GPRO)
41.71
-0 (-0%)
| GEN-PROBE (NASDAQ:GPRO) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $41.71 | 52 Week High | $49.29 | ||
| Open | $41.65 | 52 Week Low | $30.01 | ||
| Day High | $41.97 | P/E | 24.68 | ||
| Day Low | $41.65 | EPS | $1.69 | ||
| Volume | 326,562 | ||||
| More GPRO Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| PKI | 4 | ANDS | 3 |
| NANO | 3 | LVS | 3 |
| ESLR | 3 | NVTL | 3 |
| DRYS | 2 | RADS | 2 |
| FSLR | 2 | SYNA | 2 |
| NANO | 2 | CERS | 2 |
Entities who have mentioned GPRO
- William Blair | View Related Stories »
- Banc of America | View Related Stories »
- Morgan Stanley | View Related Stories »
- Robert W Baird | View Related Stories »
- Needham & Co | View Related Stories »
- Deutsche Bank | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- Trading Radar | View Related Stories »
- JPMorgan | View Related Stories »
- 13G | View Related Stories »
- Dividend | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- ThinkEquity | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
- RBC Capital | View Related Stories »
- Rodman & Renshaw | View Related Stories »
- Jim Cramer | View Related Stories »
- New Enterprise Associates | View Related Stories »
- Citi | View Related Stories »
- Wachovia | View Related Stories »
- UBS | View Related Stories »
- Matrix USA | View Related Stories »
- Stock Buyback | View Related Stories »
- Cowen & Co | View Related Stories »
- Lazard | View Related Stories »
View All Major News StreetInsider.com Major News for GPRO
- Gen-Probe (GPRO) Tops Q3 EPS by 6c; Narrows Guidance
- Gen-Probe (GPRO) Reports Mixed Q2 Results; Guides
- Gen-Probe (GPRO) Tops Q1 Earnings Views; Guides FY09
View All ReportsStreetInsider.com Reports on GPRO
- Natixis Bleichroeder Initiates Coverage on Gen-Probe (GPRO) with a Buy
- Gen-Probe (GPRO) Tops Q3 EPS by 6c; Narrows Guidance
- Gen-Probe (GPRO) Gets Emergency Use Authorizaton From U.S. FDA for Prodesse ProFlu-ST Test
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- William Blair Upgrades Gen-Probe (GPRO) to Outperform
View All Press ReleasesCompany Press Releases on GPRO
- Trading Review for Cerus Corp. Issued by Beacon Equity
- Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts
- Xenomics, Inc. and Its Subsidiary TrovaGene, Inc. Announce HPV Patent Filing Based on Transrenal DNA Technology
- Gen-Probe to Webcast Two Upcoming Investor Presentations
- Gen-Probe Reports Financial Results for Third Quarter 2009
StreetInsider Reports on GPRO by Category
View All BlogsBlogs on GPRO
- EXACT Sciences: 8 Points Following Q2 Earnings
- Gen-Probe Trims Guidance
- 20 Stocks with High Net Cash
- Where Might Genentech Investors Redeploy $47B?
- Gen Probe, Inc., Q4 2008 Earnings Call Transcript
View All FilingsSEC Filings on GPRO
- Form 4 GEN PROBE INC For: Nov 17 Filed by: NORDHOFF HENRY L
- Form 4 GEN PROBE INC For: Nov 17 Filed by: Kondor Stephen J
- Form SC 13G/A GEN PROBE INC Filed by: MORGAN STANLEY
- Form 10-Q GEN PROBE INC For: Sep 30
- Form 8-K GEN PROBE INC For: Oct 29
Comments on GPRO
No comments are currently available.
